SAN FRANCISCO, March 13, 2025 (GLOBE NEWSWIRE) -- Montara Therapeutics, a biotech company pioneering brain-selective therapies for CNS diseases, today announced the closing of a $20 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback